Suppression of cytokine production by glucocorticoids is mediated by MKP-1 in human lung epithelial cells

被引：0
作者：
Tiina Keränen
Eeva Moilanen
Riku Korhonen
机构：
[1] University of Tampere,The Immunopharmacology Research Group, University of Tampere School of Medicine, and Tampere University Hospital
来源：
Inflammation Research | 2017年 / 66卷
关键词：
MKP-1; DUSP1; Cytokine; Inflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Mitogen-activated protein kinase phosphatase 1 (MKP-1) expression is induced by inflammatory factors and serves as an endogenous p38 MAPK suppressor to limit inflammatory response. Glucocorticoids are very effective anti-inflammatory drugs and they are used for the treatment of many inflammatory diseases, such as asthma and COPD. We investigated the role of MKP-1 in the inhibition of cytokine production by dexamethasone in human A549 bronchial epithelial cells. We found that dexamethasone increased MKP-1 expression, inhibited p38 MAPK phosphorylation, and suppressed TNF and MIP-3α production in A549 cells. Interestingly, the suppression of p38 MAPK phosphorylation and the inhibition of TNF expression by dexamethasone were attenuated in cells, where MKP-1 expression was silenced by siRNA. In conclusion, these data suggest that dexamethasone increases MKP-1 expression and this results in the suppression of p38 MAPK signaling leading to the inhibition of cytokine production in human bronchial epithelial cells. These results point to the role of MKP-1 as an important factor in the therapeutic effects of glucocorticoids in the treatment of inflammatory lung diseases.
引用
收藏
页码：441 / 449
页数：8
相关论文
共 208 条
  • [11] Flavell RA(2006)MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock J Exp Med 203 131-140
  • [12] Liu Y(2010)Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs Arthritis Rheum 62 1650-1659
  • [13] Shepherd EG(2013)Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1 Br J Pharmacol 169 1525-1536
  • [14] Nelin LD(2009)A non-redundant role for MKP5 in limiting ROS production and preventing LPS-induced vascular injury EMBO J 28 2896-2907
  • [15] Wancket LM(2006)Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1 Nat Immunol 7 274-283
  • [16] Frazier WJ(2007)Anti-inflammatory functions of glucocorticoid-induced genes. Mol Cell Endocrinol 275 79-97
  • [17] Liu Y(2011)Glucocorticosteroids: current and future directions Br J Pharmacol 163 29-43
  • [18] Boutros T(2010)Transcriptional regulation of human dual specificity protein phosphatase 1 (DUSP1) gene by glucocorticoids PLoS ONE 5 e13754-2059
  • [19] Chevet E(2012)Corticosteroids and β(2)-agonists upregulate mitogen-activated protein kinase phosphatase 1: in vitro mechanisms Br J Pharmacol 166 2049-1889
  • [20] Metrakos P(2006)Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 J Exp Med 203 1883-13679
12345678910